Skip to Main Content
Advertisement
Close
AACR Journals
Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics
For Authors
Information for Authors
Author Services
Journal Awards
Best of: Author Profiles
About Us
AACR Journals
Advertising
Permissions & Reprints
Subscriptions
Submit
Article Collections
Journal Collections
Hot Topics
'Best Of' Collection
Editors' Picks
COVID-19
Webinars
Search Dropdown Menu
header search
search input
Search input auto suggest
Search
Advanced Search
User Tools Dropdown
Register
Sign In
Toggle Menu
Menu
About
The Journal
AACR Journals
Subscriptions
Permissions and Reprints
Articles
Online First
Issues
Meeting Abstracts
Cancer Research Landmarks
Collection: Targeting the Tumor Microenvironment
Collection: Tumor-Host Interactions
Collection: Focus on Computer Resources
Collection: Editors' Picks
Collection: 'Best 'Of' Collection
For Authors
Information for Authors
Author Services
Best of: Author Profiles
Early Career Award
Submit
Alerts
News
COVID-19
Webinars
Skip Nav Destination
Issues
Select Decade
2020
2010
2000
1990
1980
1970
1960
1950
1940
Select Year
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Issue
1 January - Volume 79, Issue 1, Pages 1 - 298
15 January - Volume 79, Issue 2, Pages 299 - 419
1 February - Volume 79, Issue 3, Pages 421 - 685
15 February - Volume 79, Issue 4, Pages 687 - 876
15 February - Volume 79, Issue 4_Supplement
1 March - Volume 79, Issue 5, Pages 877 - 1016
15 March - Volume 79, Issue 6, Pages 1017 - 1260
1 April - Volume 79, Issue 7, Pages 1261 - 1716
15 April - Volume 79, Issue 8, Pages 1717 - 2085
1 May - Volume 79, Issue 9, Pages 2087 - 2444
15 May - Volume 79, Issue 10, Pages 2445 - 2794
1 June - Volume 79, Issue 11, Pages 2795 - 3008
15 June - Volume 79, Issue 12, Pages 3009 - 3151
1 July - Volume 79, Issue 13, Pages 3153 - 3525
1 July - Volume 79, Issue 13_Supplement, Pages 1 - 5314
15 July - Volume 79, Issue 14, Pages 3527 - 3793
1 August - Volume 79, Issue 15, Pages 3795 - 3991
15 August - Volume 79, Issue 16, Pages 3993 - 4306
1 September - Volume 79, Issue 17, Pages 4307 - 4553
15 September - Volume 79, Issue 18, Pages 4555 - 4797
1 October - Volume 79, Issue 19, Pages 4799 - 5127
15 October - Volume 79, Issue 20, Pages 5129 - 5459
1 November - Volume 79, Issue 21, Pages 5461 - 5682
15 November - Volume 79, Issue 22, Pages 5683 - 5897
1 December - Volume 79, Issue 23, Pages 5899 - 6054
15 December - Volume 79, Issue 24, Pages 6055 - 6246
15 December - Volume 79, Issue 24_Supplement
Volume 79, Issue 13_Supplement
1 July 2019
ISSN 0008-5472
EISSN 1538-7445
Close mobile search navigation
In this Issue
Tumor Biology
Immunology
Endocrinology
Clinical Trials
Epidemiology
Experimental and Molecular Therapeutics
Cancer Chemistry
Clinical Research (Excluding Clinical Trials)
Regulatory Science and Policy
Molecular and Cellular Biology / Genetics
Bioinformatics, Convergence Science, and Systems Biology
Prevention, Early Detection, and Interception
Science and Health Policy
Issue Navigation
Search within issue:
Search within issue
Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA
Tumor Biology
Immunology
Endocrinology
Clinical Trials
Epidemiology
Experimental and Molecular Therapeutics
Cancer Chemistry
Clinical Research (Excluding Clinical Trials)
Regulatory Science and Policy
Molecular and Cellular Biology / Genetics
Bioinformatics, Convergence Science, and Systems Biology
Prevention, Early Detection, and Interception
Science and Health Policy
All Issues
Advertisement
Email alerts
eTOC Alert
Close Modal
Latest
Most Read
Most Cited
Autocrine GMCSF Signaling Contributes to Growth of HER2
+
Breast Leptomeningeal Carcinomatosis
Sustained oncogenic signaling in the cytostatic state enables targeting of non-proliferating persistent cancer cells
CDK4/6 inhibition enhances oncolytic virus efficacy by potentiating tumor-selective cell killing and T cell activation in refractory glioblastoma
Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to
our privacy policy.
Accept
